Original Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2011; 17(35): 3976-3985
Published online Sep 21, 2011. doi: 10.3748/wjg.v17.i35.3976
Table 1 Epidemiological and clinicopathological characteristics n (%)
P value1Badprognosis (n = 14)Goodprognosis(n = 31)Allpatients(n = 45)
Age (yr)0.367475.575
Median (range)57-8647-8847-88
Sex0.31
Male11 (79)18 (58)29 (64)
Female3 (21)13 (42)16 (36)
Ethnicity0.46
Ashkenazi12 (86)22 (71)34 (76)
Sephardic2 (14)9 (29)11 (24)
Surgery type0.02a
Partial gastrectomy3 (21)18 (58)21(47)
Subtotal gastrectomy2 (14)4 (13)6 (13)
Total gastrectomy4 (29)4 (13)8 (18)
Esophagogastrectomy5 (36)5 (16)10 (22)
Tumor location0.14
Proximal7 (50)12 (39)19 (42)
Distal3 (21)17 (55)20 (44)
Diffuse4 (29)2 (6)6 (13)
T stage0.001b
T10 (0)6 (23)6 (13)
T21 (7)12 (37)13 (29)
T312 (86)13 (40)25 (56)
T41 (7)0 (0)1 (2)
N Stage0.014c
N05 (36)23 (74)28 (62)
N16 (43)7 (23)13 (29)
N23 (21)1 (3)4 (9)
TNM Stage0.036
I1 (8)14 (45)15 (34)
II4 (31)11 (35)15 (34)
III8 (62)6 (19)14 (32)
Grad0.6
I0 (0)4 (13)4 (9)
II6 (43)15 (48)21 (47)
III8 (57)12 (39)20 (44)
Examined lymph nodes0.89
≤ 106 (43)13 (42)19 (42)
> 107 (57)18 (58)26 (58)
Mucin secretion1
Yes2 (14)4 (13)6 (13)
No12 (86)27 (87)39 (87)
Signet0.900
Yes2 (14)4 (13)6 (13)
No12 (86)27 (87)39 (87)
Vascular invasion0.085
Yes5 (36)3 (10)8 (18)
No9 (64)28 (90)37 (82)
Perineural invasion0.64
Yes2 (14)3 (10)5 (11)
No12 (86)28 (90)40 (89)
Site of recurrence21.4 × 10-5
Locoregional3 (21)0 (0)3 (6)
Distant7 (50)1 (3)8 (18)
Combined4 (29)3 (10)7 (16)